Hypertensive Disorders of Pregnancy clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
open to eligible females ages 14-35
The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there…
at UCSF
Our lead scientists for Hypertensive Disorders of Pregnancy research studies include Mary Norton, MD.
Last updated: